The semaglutide vs tirzepatide comparison explores the differences between these two medications in greater detail
The 2023 update added language about counterfeit peptides and the absence of quality control in black market supply chains, reflecting the FDA's growing concern about contaminated or mislabeled products sold online
An early FAERS analysis suggested an elevated risk, prompting the FDA to investigate
Excessive urination (more than 3 liters daily) combined with excessive thirst and unintended weight loss can signal new or worsening diabetes
Olfson, M., Gerhard, T., Huang, C., Crystal, S
The insurance coverage may be inconsistent with some of their medications